Jun 3 |
Annexon Biosciences to Host Conference Call and Webcast to Discuss GBS Phase 3 Data
|
May 20 |
Annexon (ANNX) Loses -5.04% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
|
May 14 |
We Think Annexon (NASDAQ:ANNX) Can Afford To Drive Business Growth
|
May 13 |
Annexon Biosciences GAAP EPS of -$0.21 beats by $0.12
|
May 13 |
Annexon Reports First Quarter 2024 Financial Results and Key Anticipated Milestones
|
May 9 |
Annexon Biosciences to Present at the Bank of America Health Care Conference
|
May 7 |
Annexon Presents New Neuroprotection Data Showing ANX007 Protects Vision and Vision-Associated Structures in Geographic Atrophy at ARVO 2024 Annual Meeting
|
May 1 |
Annexon (ANNX) to Report Q1 Earnings: What's in the Cards?
|
May 1 |
Annexon to Present Data Reinforcing the Neuroprotective Effects of ANX007 and C1q Inhibition in Geographic Atrophy at the ARVO 2024 Annual Meeting
|
Apr 25 |
Down -43.02% in 4 Weeks, Here's Why You Should You Buy the Dip in Annexon (ANNX)
|